Massachusetts Financial Services’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-55,238
Closed -$291K 846
2023
Q4
$291K Sell
55,238
-1,744
-3% -$6.9K ﹤0.01% 820
2023
Q3
$188K Sell
56,982
-2,184
-4% -$7.66K ﹤0.01% 834
2023
Q2
$171K Sell
59,166
-86,681
-59% -$166K ﹤0.01% 817
2023
Q1
$156K Sell
145,847
-4,124
-3% -$7.89K ﹤0.01% 836
2022
Q4
$391K Buy
149,971
+3,175
+2% +$13.9K ﹤0.01% 825
2022
Q3
$1.03M Sell
146,796
-1,337
-0.9% -$10.5K ﹤0.01% 780
2022
Q2
$1.01M Buy
148,133
+32,361
+28% +$330K ﹤0.01% 771
2022
Q1
$1.63M Buy
115,772
+98,302
+563% +$1.32M ﹤0.01% 771
2021
Q4
$253K Buy
+17,470
New +$248K ﹤0.01% 878

Other funds holding BVS

Massachusetts Financial Services's BVS Position: Q1 2024 in Review

Massachusetts Financial Services sold out of Bioventus (BVS) in Q1 2024, closing a stake of 55,238 shares — an estimated $291K sold.

Massachusetts Financial Services first reported a position in BVS in Q4 2021 and held it in 9 quarters. The position peaked at $1.63M in Q1 2022. 84 funds tracked by Wall St. Rank hold BVS as of Q1 2024.

  • Massachusetts Financial Services reported no remaining Bioventus position as of Q1 2024 after selling out during the quarter.
  • Massachusetts Financial Services sold 55,238 Bioventus shares in Q1 2024, an estimated $291K.
  • Massachusetts Financial Services first reported a position in Bioventus in Q4 2021 and held it in 9 quarters.
  • Massachusetts Financial Services's Bioventus position peaked at $1.63M in Q1 2022.
  • 84 funds tracked by Wall St. Rank held Bioventus as of Q1 2024.

Based on Massachusetts Financial Services's 13F filing for Q1 2024, filed 14 May 2024.